Second transplant shows promise for High-Risk myeloma
NCT ID NCT00466674
First seen Jan 07, 2026 · Last updated May 18, 2026 · Updated 24 times
Summary
This study tested whether a second stem cell transplant from a matched donor could help younger myeloma patients (under 65) who had a good response to their first transplant. Thirteen patients received a reduced-intensity conditioning regimen followed by donor stem cells. The goal was to improve event-free survival at 3 years, but patients may still need ongoing treatment or monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mohamad Sobh
Lyon, 69437, France
Conditions
Explore the condition pages connected to this study.